Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dwyer

Showing results (191-200 of 359) with videos related to

Pageof 36
Sort By:
AJNR. American Journal of Neuroradiology|June 13, 2015
Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus ErythematosusB Cesar, M G Dwyer, J L Shucard, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2021
Staging and stratifying cognitive dysfunction in multiple sclerosisCurtis Wojcik, Tom A Fuchs, Hoan Tran, et al.
Neurology|July 9, 2008
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisR Zivadinov, A T Reder, M Filippi, et al.
Clinical Neurology and Neurosurgery|December 11, 2013
Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: results of a 5-year follow-up studyOndrej Dolezal, Tereza Gabelic, Dana Horakova, et al.
BMC Neurology|June 19, 2014
MRI segmentation analysis in temporal lobe and idiopathic generalized epilepsyHila Goldberg, Arie Weinstock, Niels Bergsland, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 7, 2007
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control studyD Horakova, J L Cox, E Havrdova, et al.
Neuropsychology|July 2, 2008
Cortical atrophy and personality in multiple sclerosisRalph H B Benedict, Sarah Hussein, Jessica Englert, et al.
Experimental Neurology|September 29, 2020
Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE miceSuyog Pol, Serena Liang, Ferdinand Schweser, et al.
Journal of Neuroimmunology|April 14, 2015
Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24 weeks of therapy with subcutaneous interferon beta-1a three times weeklyMichael G Dwyer, Robert Zivadinov, Silva Markovic-Plese, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 28, 2024
Cognitive progression independent of relapse in multiple sclerosisTom A Fuchs, Menno M Schoonheim, Robert Zivadinov, et al.
Pageof 36

Showing results (191-200 of 359) with videos related to

Sort By:
Pageof 36
AJNR. American Journal of Neuroradiology|June 13, 2015
Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus ErythematosusB Cesar, M G Dwyer, J L Shucard, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2021
Staging and stratifying cognitive dysfunction in multiple sclerosisCurtis Wojcik, Tom A Fuchs, Hoan Tran, et al.
Neurology|July 9, 2008
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosisR Zivadinov, A T Reder, M Filippi, et al.
Clinical Neurology and Neurosurgery|December 11, 2013
Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: results of a 5-year follow-up studyOndrej Dolezal, Tereza Gabelic, Dana Horakova, et al.
BMC Neurology|June 19, 2014
MRI segmentation analysis in temporal lobe and idiopathic generalized epilepsyHila Goldberg, Arie Weinstock, Niels Bergsland, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 7, 2007
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control studyD Horakova, J L Cox, E Havrdova, et al.
Neuropsychology|July 2, 2008
Cortical atrophy and personality in multiple sclerosisRalph H B Benedict, Sarah Hussein, Jessica Englert, et al.
Experimental Neurology|September 29, 2020
Subcutaneous anti-CD20 antibody treatment delays gray matter atrophy in human myelin oligodendrocyte glycoprotein-induced EAE miceSuyog Pol, Serena Liang, Ferdinand Schweser, et al.
Journal of Neuroimmunology|April 14, 2015
Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24 weeks of therapy with subcutaneous interferon beta-1a three times weeklyMichael G Dwyer, Robert Zivadinov, Silva Markovic-Plese, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 28, 2024
Cognitive progression independent of relapse in multiple sclerosisTom A Fuchs, Menno M Schoonheim, Robert Zivadinov, et al.
Pageof 36